Halozyme Therapeutics Inc... (HALO)
NASDAQ: HALO
· Real-Time Price · USD
68.97
1.70 (2.53%)
At close: Aug 18, 2025, 3:59 PM
69.00
0.05%
After-hours: Aug 18, 2025, 07:50 PM EDT
Halozyme Therapeutics Revenue
Halozyme Therapeutics reported an annual revenue of $1.02B, reflecting a 22.44% growth. For the quarter ending June 30, 2025, Halozyme Therapeutics generated $325.72M in revenue.
Revenue (ttm)
1.02B
Revenue Growth
22.44%
Price / Sales Ratio
5.97
Revenue / Employee
2.9M
Employees
350
Market Cap
8.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 1.02B | +22.44% |
| Dec 31, 2023 | 829.25M | +25.62% |
| Dec 31, 2022 | 660.12M | +48.91% |
| Dec 31, 2021 | 443.31M | +65.67% |
| Dec 31, 2020 | 267.59M | +36.53% |
| Dec 31, 2019 | 195.99M | +29.06% |
| Dec 31, 2018 | 151.86M | -52.04% |
| Dec 31, 2017 | 316.61M | +115.84% |
| Dec 31, 2016 | 146.69M | +8.61% |
| Dec 31, 2015 | 135.06M | +79.28% |
| Dec 31, 2014 | 75.33M | +37.47% |
| Dec 31, 2013 | 54.8M | +29.47% |
| Dec 31, 2012 | 42.33M | -24.54% |
| Dec 31, 2011 | 56.09M | +311.67% |
| Dec 31, 2010 | 13.62M | -0.35% |
| Dec 31, 2009 | 13.67M | +55.99% |
| Dec 31, 2008 | 8.76M | +130.66% |
| Dec 31, 2007 | 3.8M | +287.02% |
| Dec 31, 2006 | 981.75K | +671.76% |
| Dec 31, 2005 | 127.21K | +Infinity% |
| Dec 31, 2004 | 0 | -100.00% |
| Dec 31, 2003 | 25.7K | -70.71% |
| Dec 31, 2002 | 87.77K | +255.56% |
| Dec 31, 2001 | 24.68K | n/a |